| target disease | drug | lead compound | optimization | pre-clinical | Phase 1 Clinical | Phase 2 Clinical | Phase 3 Clinical | Outcome |
|---|---|---|---|---|---|---|---|---|
| Dry AMD (SM) | JL2322m | 23.2Q-24.4Q | L/O | 25.1Q L/O | ||||
| JL2433a | 23.2Q-24.4Q | L/O | 25.1Q L/O | |||||
| JL2593r | 24.4Q | 글로벌 공동임상(Exp) | ||||||
| JL3175p | 22.2Q-24.4Q | 24.1Q-24.4Q | 25.2Q- | 24.12 IND | ||||
| Wet AMD (SM) | JL1662p | 22.2Q-24.4Q | 24.1Q-24.4Q | 25.2Q- | 24.12 IND | |||
| JL3661a | 22.2Q-24.4Q | 24.1Q-24.4Q | 25.2Q- | 24.12 IND | ||||
| JL334h | 22.2Q- | |||||||
| Wet AMD / Dry AMD New double AMD target |
JL6329 | 22.2Q- | Target validation, Lead optimization | |||||
| JL6169 | 22.2Q- | |||||||
| JL5280 | 22.2Q- | |||||||
| Wet AMD New AMD target | JL2022Sab | 22.2Q- | Ab Design, Ab order, CMO searching | |||||
| Products | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Julia Formula One | 2022. 6. 25 | ||||
| Julia Formula Two | 2022. 6. 25 |
Research Network - Business Model
Julia Omics Platform
Julia Drug Candidate Database
Julia Drug Design Platform
Julia Drug Delivery Platform
Retina/RPE Cell Biology
Target Validation
Retina Apoptosis
Pre-Clinical Design
Angiogenesis
Oxidative Stress
Pre-Clinical Study
Pre-Clinical Study
Clinical Study
SHC1 NRP1
타겟구조 생화학
Candidate Docking
Clinical Design
COPYRIGHT ⓒ JULIA LABORATORY. ALL RIGHTS RESERVED. DESIGNED BY MARVEL WORKS
ENG 
KOR